FDA Enforcement Class II Ongoing

A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).

Recall: Z-1043-2026 · Reported January 21, 2026

Enforcement

Recall Number
Z-1043-2026
Event ID
98097
Classification
Class II
Status
Ongoing
Product Type
Devices
Firm
Medtronic Neuromodulation
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Report Date
January 21, 2026
Initiation Date
December 3, 2025
Classification Date
January 9, 2026
Address
7000 Central Ave Ne, Minneapolis, MN, 55432-3568, United States

Description

A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).

Reason

Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.

Code Info

version 2.0.2465 and 2.0.2683 UDI-DI (GTIN) 00763000520083 Affected product is the software. Implanted Vanta Neurostimulator devices are not affected.

Distribution

Worldwide - US Nationwide distribution.

Quantity

7123